Hunan Dehai Pharmaceutical Co., Ltd. agreed to acquire Hunan Dehai Pharmaceutical Trading Co., Ltd. from Dahu Aquaculture Co.,Ltd. (SHSE:600257) for CNY 29.8 million on June 20, 2023. Under the terms of agreement, Hunan Dehai Pharmaceutical Co., Ltd. will pay CNY 15 million before June 30, 2023 and the remaining will be paid within 6 months after completion of transaction. As of December 31, 2022, Hunan Dehai Pharmaceutical Trading Co., Ltd. reported total assets of CNY 158.9615 million, net assets of CNY 37.8852 million, operating income of CNY 131.8377 million and net profit of CNY -4.5994 million.

The transaction is approved by the board of directors of Dahu Aquaculture.